Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
Actinium Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.88M | -15.94M | -6.65M | -11.57M | -11.35M | -8.67M | -9.32M | -13.28M | -15.18M | -11.04M | -10.65M | -9.47M | -7.77M | -5.13M | -8.01M | -6.42M | -5.02M | -5.32M |
Depreciation & Amortization | 204K | 205K | 204K | 202K | 189K | 216K | 199K | 200K | 209K | 182K | 161K | 221K | 180K | 137K | 137K | 133K | 129K | 125K |
Stock-Based Compensation | 197K | 8.87M | 1.2M | 1.34M | 1.37M | 1.38M | 927K | 921K | 1M | 993K | 979K | 970K | 425K | 421K | 448K | 411K | 459K | 376K |
Other Working Capital | -109K | 332K | -877K | 36K | 154K | 142K | 904K | 1.52M | -949K | -5.21M | -2.63M | 466K | 367K | -935K | 1.18M | 291K | -151K | -211K |
Other Non-Cash Items | n/a | n/a | n/a | -426K | n/a | n/a | 1.52M | 1.81M | 142K | n/a | 38.17M | -690K | 34.71M | 970K | 1.69M | 330K | 1.02M | 1.24M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.52M | -1.81M | -142K | n/a | -38.17M | 690K | n/a | n/a | -1.69M | n/a | n/a | n/a |
Change in Working Capital | 1.08M | -715K | -506K | -1.52M | 1.82M | -298K | 708K | 1.03M | 328K | -5.21M | 1.73M | 2.57M | 35.08M | -1.21M | 2.37M | 291K | -151K | -823K |
Operating Cash Flow | -5.39M | -7.57M | -5.75M | -11.97M | -7.97M | -7.37M | -7.49M | -11.13M | -13.64M | -15.08M | -7.78M | -5.71M | 27.92M | -5.78M | -5.05M | -5.59M | -4.58M | -5.64M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -11K | n/a | -30K | -47K | -76K | -16K | -73K | -270K | -7K | n/a | -68K | -61K | -4K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -11K | n/a | -30K | -47K | -76K | -16K | -73K | -270K | -7K | n/a | -68K | -61K | -4K |
Debt Repayment | -3K | -2K | -2K | -2K | -3K | -2K | -1K | -1K | -1K | -1K | -1K | -3K | -23K | -22K | -22K | -21K | -21K | -21K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 75K | n/a | n/a | 261K | 1K | n/a | 1.58M | n/a | n/a | n/a | n/a | 6K | n/a |
Financial Cash Flow | -3K | -2K | -3K | 4.6M | 9.95M | 14.77M | 1.19M | 2.86M | 10.05M | 770K | 4.89M | 1.57M | 16.66M | -22K | 801K | 5.78M | 14.3M | 14.34M |
Net Cash Flow | -5.39M | -7.58M | -5.75M | -7.37M | 1.98M | 7.38M | -6.3M | -8.29M | -3.64M | -14.38M | -2.9M | -4.21M | 44.31M | -5.81M | -4.25M | 120K | 9.66M | 8.69M |
Free Cash Flow | -5.39M | -7.57M | -5.75M | -11.97M | -7.97M | -7.38M | -7.49M | -11.15M | -13.69M | -15.15M | -7.79M | -5.79M | 27.65M | -5.79M | -5.05M | -5.66M | -4.64M | -5.65M |